For everyone who might think CHM is rooted ...and clearly there are a lot of people who do .
1. @Krushinlt posted regarding the presentation yesterday & thanks for doing so - see text below .
"I attended today's briefing in Sydney:- Well attended and generally upbeat;
- Rebecca was articulate and hit the right notes with her presentation;
- Wouldnt be surprised if she steps into the CEO role at some future date;
- All 4 clinical trials are progressing well;
- Interim data read outs are expected in Q3 and Q4. (Earlier than expected!);
- She confirmed my view that CDH17 is the jewel in the crown - biggest addressable market and leading tech in-licensed from the pioneers of CART therapies;
- FDA interactions have been positive - Orphan Drug Status will be a no brainer for some of the therapies. Similarly, Fast Track Designation definitely on the cards;
- Paul Hopper did not attend as he was OS on other business (disappointing but I knew he was not in AU);"
2. There are quite a few players in the CarT Field ...... & given the minute market cap of CHM at current prices ..... if there is a "sniff of interest " in what CHM are are doing ..... a valuation on the IP could come in at 10 - 20 times the current market cap of CHM .
3. People who subscribed to the float @ 30 cents ( assuming there are some left ) could do a lot worse than to pick up more stock at 1 / 13th of the price they paid for it X 3 - 4 Years ago .
4. A lot of believers picked up stock @ 7- 8 cents ...and lower - clearly the stock is right out of favour
5. I'm expecting a tirade of moaning form Steini about Paul Hopper etc etc etc ---- ignore that broken record - its been done to death ! ( no offence man ) - think about the IP and the current progress and where this could go
Thats my thought for the day ...... and lets see what evolves down the track
LOL
(20min delay)